Literature DB >> 25383459

Association between morphologic CT imaging traits and prognostically relevant gene signatures in women with high-grade serous ovarian cancer: a hypothesis-generating study.

Hebert Alberto Vargas1, Maura Miccò, Seong Im Hong, Debra A Goldman, Fanny Dao, Britta Weigelt, Robert A Soslow, Hedvig Hricak, Douglas A Levine, Evis Sala.   

Abstract

PURPOSE: To investigate associations among imaging traits observed on computed tomographic (CT) images, Classification of Ovarian Cancer (CLOVAR) gene signatures, and survival in women with high-grade serous ovarian cancer (HGSOC).
MATERIALS AND METHODS: The institutional review board approved this HIPAA-compliant retrospective study of CT images obtained before cytoreductive surgery in 46 women with HGSOC, whose tumors were subjected to molecular analysis performed by the Cancer Genome Atlas Research Network. Two readers independently evaluated the CT features of the primary ovarian mass and sites of metastatic spread if present, including size, outline, and texture. Fisher exact test was used to examine the relationship between imaging traits and CLOVAR subtypes (CLOVAR differentiated, immunoreactive, mesenchymal, and proliferative). Kaplan-Meier and Cox proportional hazards regression survival analyses were performed.
RESULTS: The presence of mesenteric infiltration and diffuse peritoneal involvement by tumor at CT were significantly associated with CLOVAR subtype (P = .002-.004 for reader 1 and P = .005-.012 for reader 2). Mesenteric infiltration at CT was associated with CLOVAR mesenchymal subtype. Patients with mesenteric infiltration had shorter median progression-free survival than patients without mesenteric involvement (14.7 months vs 25.6 months according to both readers; P = .019 for reader 1 and .015 for reader 2) and overall survival (49.0 vs 58.2 months; P = .014 [reader 1] and 50.0 vs 59.1 months; P = .015 [reader 2]). No other imaging features were significantly associated with CLOVAR subtype or survival.
CONCLUSION: Specific CT imaging traits were associated with the CLOVAR subtypes and survival in patients with HGSOC.

Entities:  

Mesh:

Year:  2014        PMID: 25383459      PMCID: PMC4455661          DOI: 10.1148/radiol.14141477

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  23 in total

1.  Gene expression signature with independent prognostic significance in epithelial ovarian cancer.

Authors:  Dimitrios Spentzos; Douglas A Levine; Marco F Ramoni; Marie Joseph; Xuesong Gu; Jeff Boyd; Towia A Libermann; Stephen A Cannistra
Journal:  J Clin Oncol       Date:  2004-10-25       Impact factor: 44.544

2.  Analysis of gene expression profiles in normal and neoplastic ovarian tissue samples identifies candidate molecular markers of epithelial ovarian cancer.

Authors:  J B Welsh; P P Zarrinkar; L M Sapinoso; S G Kern; C A Behling; B J Monk; D J Lockhart; R A Burger; G M Hampton
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-30       Impact factor: 11.205

3.  Distinction between serous tumors of low malignant potential and serous carcinomas based on global mRNA expression profiling.

Authors:  C Blake Gilks; Barbara C Vanderhyden; Shirley Zhu; Matt van de Rijn; Teri A Longacre
Journal:  Gynecol Oncol       Date:  2005-03       Impact factor: 5.482

4.  The measurement of observer agreement for categorical data.

Authors:  J R Landis; G G Koch
Journal:  Biometrics       Date:  1977-03       Impact factor: 2.571

5.  Quantification of radiation-induced lung damage with CT scans: the possible benefit for radiogenomics.

Authors:  Dirk De Ruysscher; Hoda Sharifi; Gilles Defraene; Sarah L Kerns; Melissa Christiaens; Kim De Ruyck; Stéphanie Peeters; Johan Vansteenkiste; Robert Jeraj; Frank Van Den Heuvel; Wouter van Elmpt
Journal:  Acta Oncol       Date:  2013-08-19       Impact factor: 4.089

6.  Gene expression profiles predict early relapse in ovarian cancer after platinum-paclitaxel chemotherapy.

Authors:  Lynn C Hartmann; Karen H Lu; Gerald P Linette; William A Cliby; Kimberly R Kalli; David Gershenson; Robert C Bast; James Stec; Natalia Iartchouk; David I Smith; Jeffrey S Ross; Sebastian Hoersch; Viji Shridhar; James Lillie; Scott H Kaufmann; Edwin A Clark; Andrew I Damokosh
Journal:  Clin Cancer Res       Date:  2005-03-15       Impact factor: 12.531

7.  Invasion patterns of metastatic high-grade serous carcinoma of ovary or fallopian tube associated with BRCA deficiency.

Authors:  M Carolina Reyes; Angela G Arnold; Noah D Kauff; Douglas A Levine; Robert A Soslow
Journal:  Mod Pathol       Date:  2014-02-28       Impact factor: 7.842

8.  Gene expression patterns in ovarian carcinomas.

Authors:  Marci E Schaner; Douglas T Ross; Giuseppe Ciaravino; Therese Sorlie; Olga Troyanskaya; Maximilian Diehn; Yan C Wang; George E Duran; Thomas L Sikic; Sandra Caldeira; Hanne Skomedal; I-Ping Tu; Tina Hernandez-Boussard; Steven W Johnson; Peter J O'Dwyer; Michael J Fero; Gunnar B Kristensen; Anne-Lise Borresen-Dale; Trevor Hastie; Robert Tibshirani; Matt van de Rijn; Nelson N Teng; Teri A Longacre; David Botstein; Patrick O Brown; Branimir I Sikic
Journal:  Mol Biol Cell       Date:  2003-09-05       Impact factor: 4.138

9.  Gene expression in ovarian cancer reflects both morphology and biological behavior, distinguishing clear cell from other poor-prognosis ovarian carcinomas.

Authors:  Donald R Schwartz; Sharon L R Kardia; Kerby A Shedden; Rork Kuick; George Michailidis; Jeremy M G Taylor; David E Misek; Rong Wu; Yali Zhai; Danielle M Darrah; Heather Reed; Lora H Ellenson; Thomas J Giordano; Eric R Fearon; Samir M Hanash; Kathleen R Cho
Journal:  Cancer Res       Date:  2002-08-15       Impact factor: 12.701

10.  Mutational landscape and significance across 12 major cancer types.

Authors:  Cyriac Kandoth; Michael D McLellan; Fabio Vandin; Kai Ye; Beifang Niu; Charles Lu; Mingchao Xie; Qunyuan Zhang; Joshua F McMichael; Matthew A Wyczalkowski; Mark D M Leiserson; Christopher A Miller; John S Welch; Matthew J Walter; Michael C Wendl; Timothy J Ley; Richard K Wilson; Benjamin J Raphael; Li Ding
Journal:  Nature       Date:  2013-10-17       Impact factor: 49.962

View more
  21 in total

1.  High-Grade Serous Ovarian Cancer: Associations between BRCA Mutation Status, CT Imaging Phenotypes, and Clinical Outcomes.

Authors:  Stephanie Nougaret; Yulia Lakhman; Mithat Gönen; Debra A Goldman; Maura Miccò; Melvin D'Anastasi; Sarah A Johnson; Krishna Juluru; Angela G Arnold; Ramon E Sosa; Robert A Soslow; Hebert Alberto Vargas; Hedvig Hricak; Noah D Kauff; Evis Sala
Journal:  Radiology       Date:  2017-06-16       Impact factor: 11.105

2.  A novel representation of inter-site tumour heterogeneity from pre-treatment computed tomography textures classifies ovarian cancers by clinical outcome.

Authors:  Hebert Alberto Vargas; Harini Veeraraghavan; Maura Micco; Stephanie Nougaret; Yulia Lakhman; Andreas A Meier; Ramon Sosa; Robert A Soslow; Douglas A Levine; Britta Weigelt; Carol Aghajanian; Hedvig Hricak; Joseph Deasy; Alexandra Snyder; Evis Sala
Journal:  Eur Radiol       Date:  2017-03-13       Impact factor: 5.315

Review 3.  Background, current role, and potential applications of radiogenomics.

Authors:  Katja Pinker; Fuki Shitano; Evis Sala; Richard K Do; Robert J Young; Andreas G Wibmer; Hedvig Hricak; Elizabeth J Sutton; Elizabeth A Morris
Journal:  J Magn Reson Imaging       Date:  2017-11-02       Impact factor: 4.813

4.  Radiogenomics of High-Grade Serous Ovarian Cancer: Multireader Multi-Institutional Study from the Cancer Genome Atlas Ovarian Cancer Imaging Research Group.

Authors:  Hebert Alberto Vargas; Erich P Huang; Yulia Lakhman; Joseph E Ippolito; Priya Bhosale; Vincent Mellnick; Atul B Shinagare; Maria Anello; Justin Kirby; Brenda Fevrier-Sullivan; John Freymann; C Carl Jaffe; Evis Sala
Journal:  Radiology       Date:  2017-06-22       Impact factor: 11.105

5.  Construction and Verification of a Predictive Model for Risk Factors in Children With Severe Adenoviral Pneumonia.

Authors:  Yaqiong He; Peng Liu; Leyun Xie; Saizhen Zeng; Huashan Lin; Bing Zhang; Jianbin Liu
Journal:  Front Pediatr       Date:  2022-06-27       Impact factor: 3.569

6.  Invasion Patterns of Metastatic Extrauterine High-grade Serous Carcinoma With BRCA Germline Mutation and Correlation With Clinical Outcomes.

Authors:  Yaser R Hussein; Jennifer A Ducie; Angela G Arnold; Noah D Kauff; Hebert A Vargas-Alvarez; Evis Sala; Douglas A Levine; Robert A Soslow
Journal:  Am J Surg Pathol       Date:  2016-03       Impact factor: 6.394

7.  Does the method of primary treatment affect the pattern of first recurrence in high-grade serous ovarian cancer?

Authors:  Yuki Himoto; Paulina Cybulska; Fuki Shitano; Evis Sala; Junting Zheng; Marinela Capanu; Stephanie Nougaret; Ines Nikolovski; Hebert A Vargas; Wei Wang; Jennifer J Mueller; Dennis S Chi; Yulia Lakhman
Journal:  Gynecol Oncol       Date:  2019-09-12       Impact factor: 5.482

8.  Metabolic tumor burden predicts prognosis of ovarian cancer patients who receive platinum-based adjuvant chemotherapy.

Authors:  Makoto Yamamoto; Tetsuya Tsujikawa; Yuko Fujita; Yoko Chino; Tetsuji Kurokawa; Yasushi Kiyono; Hidehiko Okazawa; Yoshio Yoshida
Journal:  Cancer Sci       Date:  2016-02-23       Impact factor: 6.716

Review 9.  Update on Imaging of Ovarian Cancer.

Authors:  Rosemarie Forstner; Matthias Meissnitzer; Teresa Margarida Cunha
Journal:  Curr Radiol Rep       Date:  2016-04-09

10.  Hyaluronic acid-modified manganese-chelated dendrimer-entrapped gold nanoparticles for the targeted CT/MR dual-mode imaging of hepatocellular carcinoma.

Authors:  Ruizhi Wang; Yu Luo; Shuohui Yang; Jiang Lin; Dongmei Gao; Yan Zhao; Jinguo Liu; Xiangyang Shi; Xiaolin Wang
Journal:  Sci Rep       Date:  2016-09-22       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.